Sarepta Therapeutics CEO Ingram to retire by year end - Reuters

Reuters | Feb. 26, 2026, 5:05 a.m. | Original
Sarepta Therapeutics CEO Ingram to retire by year end Reuters
Markets rangebound while inventories hold steady - TradingView Export prices stagnant on muted demand, robust supply - TradingView